ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
Conditions: ANCA Associated Vasculitis; Cardiovascular Diseases; Kidney Diseases Intervention: Drug: Sparsentan Sponsors: University of Edinburgh; Travere Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials
CXCR4-PET/CT in GCA
Conditions: Vasculitis; Diagnoses Disease Intervention: Diagnostic Test: CXCR4-PET Sponsor: Matthias Fröhlich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2022 Category: Research Source Type: clinical trials